Defective drug litigation is an area of products liability that holds pharmaceutical companies, manufacturers, and distributors liable for dangerous drugs that result in injury, illness, or wrongful death. At Baggett McCall LLC, our Lake Charles dangerous drugs lawyers offer strategic advocacy to protect the rights of our clients and maximize compensation for losses resulting from defective drugs.
Defective drug litigation can be complex. Be careful to choose a lawyer to handle your case who has had success in all aspects of litigation, from the investigation of dangerous drugs through assessment of damages. Contact our personal injury attorneys today for an initial consultation or case evaluation.
The U.S. Food and Drug Administration (FDA) has warned that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin, all of which are SGLT2 Inhibitors, may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization. The FDA issued the warning after receiving reports of a number of cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients treated with SGLT2 inhibitors in 2013 and 2014. All patients required emergency room visits or hospitalization to treat the ketoacidosis. The FDA has continued to receive additional reports for DKA and ketoacidosis in patients treated with SGLT2 inhibitors.
Patients should pay close attention to any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as:
Do not stop or change your diabetes medicines without first talking to your doctor. Healthcare professionals should evaluate for the presence of acidosis, including ketoacidosis, in patients experiencing these signs or symptoms; discontinue SGLT2 inhibitors if acidosis is confirmed, and take appropriate measures to correct the acidosis and monitor sugar levels.
SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with Type 2 diabetes. When untreated, Type 2 diabetes can lead to serious problems, including blindness, nerve and kidney damage, and heart disease. SGLT2 inhibitors lower blood sugar by causing the kidneys to remove sugar from the body through the urine.
After seeking treatment, you can reach out to our compassionate Lake Charles attorneys for help seeking compensation for any harm you suffered due to this dangerous diabetes medication.

If you use a pharmaceutical product that was approved by the FDA and was later found to be defective, you are generally preempted from filing a claim. This is a very difficult area of law, but our attorneys have had significant success in overcoming the challenges presented by legislation that protects pharmaceutical distributors and manufacturers. Drugs of potential concern include:
If you or someone you love has suffered because of a negligent drug company, please contact our Lake Charles attorneys immediately for a free consultation and case evaluation regarding a product recall or adverse reaction.
If you or someone you love has been injured by any dangerous pharmaceutical, please reach out to Baggett McCall LLC online for a free consultation, or call 337-478-8888 or 1-800-New-Claim (639-5246) now to speak directly with an experienced Lake Charles dangerous drugs lawyer. Choose your lawyer carefully. Contact Baggett McCall today.